53.13
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$53.48
Aprire:
$52.01
Volume 24 ore:
1.80M
Relative Volume:
0.77
Capitalizzazione di mercato:
$8.31B
Reddito:
$1.22B
Utile/perdita netta:
$81.07M
Rapporto P/E:
103.35
EPS:
0.5141
Flusso di cassa netto:
$223.02M
1 W Prestazione:
+0.82%
1M Prestazione:
-8.11%
6M Prestazione:
-14.43%
1 anno Prestazione:
-8.99%
Bio Techne Corp Stock (TECH) Company Profile
Nome
Bio Techne Corp
Settore
Industria
Telefono
612-379-8854
Indirizzo
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Compare TECH vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
TECH
Bio Techne Corp
|
53.13 | 8.31B | 1.22B | 81.07M | 223.02M | 0.5141 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-03 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-08-21 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2025-07-09 | Iniziato | TD Cowen | Buy |
| 2025-05-30 | Iniziato | Wells Fargo | Overweight |
| 2025-04-09 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-03-18 | Iniziato | Evercore ISI | Outperform |
| 2025-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-02-08 | Iniziato | Scotiabank | Sector Outperform |
| 2024-02-02 | Downgrade | Stifel | Buy → Hold |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-08-28 | Iniziato | William Blair | Outperform |
| 2023-01-10 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | Aggiornamento | Stifel | Hold → Buy |
| 2021-01-25 | Reiterato | The Benchmark Company | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-07-15 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | Downgrade | Stifel | Buy → Hold |
| 2020-05-14 | Iniziato | The Benchmark Company | Buy |
| 2020-01-08 | Ripresa | Stephens | Overweight |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-02 | Aggiornamento | Janney | Neutral → Buy |
| 2019-01-14 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | Downgrade | Craig Hallum | Buy → Hold |
| 2018-10-17 | Iniziato | Goldman | Neutral |
| 2018-06-15 | Iniziato | Argus | Buy |
| 2017-07-13 | Iniziato | Wells Fargo | Market Perform |
| 2017-02-09 | Iniziato | Citigroup | Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Buy |
| 2016-11-10 | Ripresa | Leerink Partners | Outperform |
| 2015-01-21 | Reiterato | Robert W. Baird | Outperform |
| 2013-09-20 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
Mostra tutto
Bio Techne Corp Borsa (TECH) Ultime notizie
Q1 2026 Bio-Techne Corp Earnings Call Transcript - GuruFocus
Bio-Techne Corporation (TECH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bio-Techne earnings beat by $0.03, revenue topped estimates - Investing.com
Bio-Techne Corp (1TECH.MI) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Assessing Bio-Techne (TECH) Valuation After COMET Spatial Biology Platform Expansion - Yahoo Finance
TECH Stock Price, Quote & Chart | BIO-TECHNE CORP (NASDAQ:TECH) - ChartMill
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
TECH Should I Buy - intellectia.ai
SG Americas Securities LLC Acquires 126,702 Shares of Bio-Techne Corp $TECH - MarketBeat
ETF Watch: What are the future prospects of Bio Techne Corporation2026 Catalysts & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Small-MidCap Dividend Income Fund's Bio-Techne Corp(TECH) Holding History - GuruFocus
SPYRE Focus Panel launch fails to lift Bio-Techne stock amid pronounced bearish momentum - Traders Union
Fort Washington Investment Advisors Reduces Stake in Bio-Techne - National Today
Fort Washington Investment Advisors Inc. OH Sells 146,767 Shares of Bio-Techne Corp $TECH - MarketBeat
Technical Reactions to TECH Trends in Macro Strategies - news.stocktradersdaily.com
Bio-Techne Corp. stock underperforms Friday when compared to competitors - MarketWatch
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know - Yahoo Finance
Riverbridge Partners LLC Has $46.21 Million Stake in Bio-Techne Corp $TECH - MarketBeat
Vanguard disaggregates holdings, reports 0% in Bio‑Techne (NASDAQ: TECH) - Stock Titan
Q4 Research Tools & Consumables Earnings: Bio-Techne (NASDAQ:TECH) Earns Top Marks - Yahoo Finance
Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite - The AI Journal
Bio-Techne expands spatial biology product portfolio - Investing.com
Bio-Techne expands spatial biology product portfolio By Investing.com - Investing.com UK
Bio-Techne adds tools aimed at harder-to-detect tissue targets - Stock Titan
Bio-Techne Sees Unusually Large Options Volume (NASDAQ:TECH) - MarketBeat
Bio-Techne Corp. stock rises Monday, still underperforms market - MarketWatch
Tudor Investment Corp ET AL Purchases Shares of 242,016 Bio-Techne Corp $TECH - MarketBeat
JPMorgan Chase Sells Stake in Bio-Techne Corp - National Today
JPMorgan Chase & Co. Sells 633,738 Shares of Bio-Techne Corp $TECH - MarketBeat
38,300 Shares in Bio-Techne Corp $TECH Purchased by Covea Finance - MarketBeat
After a Long Reset Period, Life Science Stocks Look Set to Rebound - Morningstar
How Is Bio-Techne's Stock Performance Compared to Other Biotechnology Stocks - Barchart.com
ELISpot & FluoroSpot Assay Market Report 2026-2031: Mabtech, Oxford Immunotec Global, and Cellular Technology Dominate the Landscape - GlobeNewswire Inc.
TECH SEC FilingsBio-Techne Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Bio-Techne Corp (NASDAQ:TECH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Bio-Techne Corp. stock underperforms Monday when compared to competitors - msn.com
Should You Continue to Hold Bio-Techne Stock in Your Portfolio? - Yahoo Finance
Risk Check: Will Bio Techne Corporation outperform the market in YEAR2026 Levels & Fast Moving Market Watchlists - baoquankhu1.vn
Bio-Techne stock falls on AI software concerns, TD Cowen sees buy opportunity - Investing.com
Mairs & Power Inc. Has $156.18 Million Stock Position in Bio-Techne Corp $TECH - MarketBeat
April McClain Delaney makes multiple stock transactions in Bio-Techne, BJ’s Wholesale, and C.H Robinson - Investing.com Nigeria
Trading the Move, Not the Narrative: (TECH) Edition - Stock Traders Daily
Hollow Brook Wealth Management Increases Stake in Bio-Techne Corp - National Today
Bio-Techne Corp $TECH Shares Acquired by Hollow Brook Wealth Management LLC - MarketBeat
Bamco Inc. NY Sells Nearly 300,000 Shares of Bio-Techne Corp - National Today
Bamco Inc. NY Sells 298,824 Shares of Bio-Techne Corp $TECH - MarketBeat
Aristotle Atlantic Partners LLC Lowers Stock Position in Bio-Techne Corp $TECH - MarketBeat
ArrowMark Colorado Holdings LLC Has $18.69 Million Stock Position in Bio-Techne Corp $TECH - MarketBeat
2Xideas AG Sells 21,436 Shares of Bio-Techne Corp $TECH - MarketBeat
Assessing Bio‑Techne (TECH) Valuation After Institutional Buying Earnings Beat And New AI Drug Discovery Push - Yahoo Finance
Is Bio-Techne Stock a Buy, Sell, or Hold After a Wealth Manager Dumps Its Entire Stake? - Yahoo Finance
Bio Techne Corp Azioni (TECH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):